The annual New Drug Therapy Approvals report is out! In 2023, CDER approved 55 novel drugs, targeting a wide range of disease areas & more than half of the novel drugs approved in 2023 were approved to prevent, diagnose or treat a rare disease or condition.
FDA Enhances Global Patient and Regulatory Collaborations in Oncology
Feb. 1 Virtual Discussion to Highlight Successes from Development to Approval
FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers
CDER approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.